CoChat

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study

Open access
Ritte, Rebecca, Lukanova, Annekatrin, Berrino, Franco, Dossus, Laure, Tjønneland, Anne, Olsen, Anja, Overvad, Thure Filskov, Overvad, Kim, Clavel-Chapelon, Françoise, Fournier, Agnès, Fagherazzi, Guy, Rohrmann, Sabine, Teucher, Birgit, Boeing, Heiner, Aleksandrova, Krasimira, Trichopoulou, Antonia, Lagiou, Pagona, Trichopoulos, Dimitrios, Palli, Domenico, Sieri, Sabina, Panico, Salvatore, Tumino, Rosario, Vineis, Paolo, Quirós, José Ramón, Buckland, Genevieve, Sánchez, Maria-José, Amiano, Pilar, Chirlaque, María-Dolores, Ardanaz, Eva, Sund, Malin, Lenner, Per, Bueno-de-Mesquita, Bas, van Gils, Carla H, Peeters, Petra HM, Krum-Hansen, Sanda, Gram, Inger Torhild, Lund, Eiliv, Khaw, Kay-Tee, Wareham, Nick, Allen, Naomi E, Key, Timothy J, Romieu, Isabelle, Rinaldi, Sabina, Siddiq, Afshan, Cox, David, Riboli, Elio, Kaaks, Rudolf · 2012 · Breast Cancer Research
Cited by 128

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Introduction: Associations of hormone-receptor positive breast cancer with excess adiposity are reasonably well characterized; however, uncertainty remains regarding the association of body mass index (BMI) with hormone-receptor negative malignancies, and possible interactions by hormone replacement therapy (HRT) use. Methods: Within the European EPIC cohort, Cox proportional hazards models were used to describe the relationship of BMI, waist and hip circumferences with risk of estrogen-receptor (ER) negative and progesterone-receptor (PR) negative (n = 1,021) and ER+PR+ (n = 3,586) breast tumors within five-year age bands. Among postmenopausal women, the joint effects of BMI and HRT use were analyzed. Results: For risk of ER-PR- tumors, there was no association of BMI across the age bands. However, when analyses were restricted to postmenopausal HRT never users, a positive risk association with BMI (third versus first tertile HR = 1.47 (1.01 to 2.15)) was observed. BMI was inversely associated with ER+PR+ tumors among women aged ≤49 years (per 5 kg/m 2 increase, HR = 0.79 (95%CI 0.68 to 0.91)), and positively associated with risk among women ≥65 years (HR = 1.25 (1.16 to 1.34)). Adjusting for BMI, waist and hip circumferences showed no further associations with risks of breast cancer subtypes. Current use of HRT was significantly associated with an increased risk of receptor-negative (HRT current use compared to HRT never use HR: 1.30 (1.05 to 1.62)) and positive tumors (HR: 1.74 (1.56 to 1.95)), although this risk increase was weaker for ER-PR- disease (P he t = 0.035). The association of HRT was significantly stronger in the leaner women (BMI ≤22.5 kg/m 2) than for more overweight women (BMI ≥25.9 kg/m 2) for, both, ER-PR- (HR: 1.74 (1.15 to 2.63)) and ER+PR+ (HR: 2.33 (1.84 to 2.92)) breast cancer and was not restricted to any particular HRT regime. Conclusions: An elevated BMI may be positively associated with risk of ER-PR- tumors among postmenopausal women who never used HRT. Furthermore, postmenopausal HRT users were at an increased risk of ER-PR- as well as ER+PR+ tumors, especially among leaner women. For hormone-receptor positive tumors, but not for hormone-receptor negative tumors, our study confirms an inverse association of risk with BMI among young women of premenopausal age. Our data provide evidence for a possible role of sex hormones in the etiology of hormone-receptor negative tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/bcr3186

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 128

Metadata

Authors
Ritte, R., Lukanova, A., Berrino, F., Dossus, L., Tjønneland, A., Olsen, A., Overvad, T. F., Overvad, K., Clavel-Chapelon, F., Fournier, A., Fagherazzi, G., Rohrmann, S., Teucher, B., Boeing, H., Aleksandrova, K., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Palli, D., Sieri, S., Panico, S., Tumino, R., Vineis, P., Quirós, J. R., Buckland, G., Sánchez, M.-J., Amiano, P., Chirlaque, M.-D., Ardanaz, E., Sund, M., Lenner, P., Bueno-de-Mesquita, B., van Gils, C. H., Peeters, P. H., Krum-Hansen, S., Gram, I. T., Lund, E., Khaw, K.-T., Wareham, N., Allen, N. E., Key, T. J., Romieu, I., Rinaldi, S., Siddiq, A., Cox, D., Riboli, E., & Kaaks, R.
Venue
Breast Cancer Research
Published
2012-05-14
Volume
14
Issue
3
Pages
R76-R76
ISSN
  • 1465-5411 (ISSN-L)
  • 1465-542X
OpenAlex
W2126396090
Cited by
128
References
4
FWCI
5.68
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. https://app.cochat.ai/papers/10.1186/bcr3186
The paper
Ritte, R., Lukanova, A., Berrino, F., Dossus, L., Tjønneland, A., Olsen, A., Overvad, T. F., Overvad, K., Clavel-Chapelon, F., Fournier, A., Fagherazzi, G., Rohrmann, S., Teucher, B., Boeing, H., Aleksandrova, K., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Palli, D., . . . Kaaks, R. (2012). Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Research. https://doi.org/10.1186/bcr3186

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.